Biodyne Co Ltd
KOSDAQ:314930
Biodyne Co Ltd
Research & Development
Biodyne Co Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Biodyne Co Ltd
KOSDAQ:314930
|
Research & Development
-₩251.8m
|
CAGR 3-Years
14%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
I
|
I Sens Inc
KOSDAQ:099190
|
Research & Development
-₩28.9B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-12%
|
|
|
C
|
Classys Inc
KOSDAQ:214150
|
Research & Development
-₩16.7B
|
CAGR 3-Years
-60%
|
CAGR 5-Years
-52%
|
CAGR 10-Years
N/A
|
|
|
W
|
Won Tech Co Ltd
KOSDAQ:336570
|
Research & Development
-₩1.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
V
|
Viol Co Ltd
KOSDAQ:335890
|
Research & Development
-₩2.9B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
Seers Technology Co Ltd
KOSDAQ:458870
|
Research & Development
-₩4.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Biodyne Co Ltd
Glance View
Biodyne Co., Ltd. engages in the development of cancer diagnosis solutions. The company is headquartered in Seoul, Seoul and currently employs 26 full-time employees. The company went IPO on 2021-03-17. The firm produces and sells LBC diagnostic equipment and diagnostic reagent kits. The firm's LBC equipment include PATHPLORER AUTO, PATHPLORER 4.7, PATHPLORER 4.63 and PATHPLORER ECO. The firm sells its products in domestic and overseas markets such as Japan, Russia, Portugal and Thailand.
See Also
What is Biodyne Co Ltd's Research & Development?
Research & Development
-251.8m
KRW
Based on the financial report for Dec 31, 2024, Biodyne Co Ltd's Research & Development amounts to -251.8m KRW.
What is Biodyne Co Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
14%
Over the last year, the Research & Development growth was 34%. The average annual Research & Development growth rates for Biodyne Co Ltd have been 14% over the past three years , 14% over the past five years .
